A Study to Create a Registry of Patients with Hypophosphatasia (HPP)

Overview

About this study

The purpose of this study is to collect information on the variability, progression, and natural history of hypophosphotasia (HPP) from patients of all ages, including infants, children, and adults with HPP, regardless of age at onset.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Male and female patients
Any age
Confirmed diagnosis of HPP
Patient or legal representative is able to read and/or understand the informed consent and study questionnaires in the local language.
Signed informed consent and medical records release by the patient or legal representative.
Patient or patient's parent/legal representative must be willing and able to give written informed consent, and the patient must be willing to give written informed assent, if appropriate and required by local regulations.

Exclusion Criteria

Currently participating in an Alexion-sponsored clinical trial
Previously received asfotase alfa
Enrollment in the Registry will not exclude a patient from enrolling in a future clinical trial

More information

Publications

Publications are currently not available

Clinical Trials